|
B3GALTL expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.86079999964228E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.03500000003809E-06 |
| Normal-vs-Stage2 |
2.541800E-02 |
| Normal-vs-Stage3 |
2.559900E-04 |
| Normal-vs-Stage4 |
2.343300E-03 |
| Stage1-vs-Stage2 |
4.190600E-01 |
| Stage1-vs-Stage3 |
7.082200E-01 |
| Stage1-vs-Stage4 |
3.415600E-01 |
| Stage2-vs-Stage3 |
3.874200E-01 |
| Stage2-vs-Stage4 |
2.714400E-01 |
| Stage3-vs-Stage4 |
4.937800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.88878999999309E-05 |
| Normal-vs-AfricanAmerican |
6.952000E-02 |
| Normal-vs-Asian |
2.586400E-02 |
| Caucasian-vs-AfricanAmerican |
6.198200E-04 |
| Caucasian-vs-Asian |
8.304400E-01 |
| AfricanAmerican-vs-Asian |
1.940760E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.09089999999579E-05 |
| Normal-vs-Female |
1.365530E-02 |
| Male-vs-Female |
2.899500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.966070E-04 |
| Normal-vs-Extreme_Weight |
5.74129999999506E-05 |
| Normal-vs-Obese |
4.019000E-04 |
| Normal-vs-Extreme_Obese |
2.807700E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.875600E-01 |
| Normal_Weight-vs-Obese |
5.960000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.572600E-01 |
| Extreme_Weight-vs-Obese |
2.729600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.707600E-01 |
| Obese-vs-Extreme_Obese |
8.065600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.301600E-03 |
| Normal-vs-Age(41-60Yrs) |
5.998300E-04 |
| Normal-vs-Age(61-80Yrs) |
1.55566999999746E-05 |
| Normal-vs-Age(81-100Yrs) |
4.395100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.832200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.253000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.661400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.356390E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.528640E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.945200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.778050E-04 |
| Normal-VS-Type2 PRCC |
8.51260000045428E-07 |
| Normal-VS-KIRP CIMP |
2.42669999983569E-07 |
| Normal-VS-Unclassified PRCC |
2.924300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.534390E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.604940E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.923370E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.806100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.984000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.645300E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.91370000000224E-05 |
| Normal-vs-N1 |
3.099900E-03 |
| Normal-vs-N2 |
6.502200E-03 |
| N0-vs-N1 |
4.499800E-01 |
| N0-vs-N2 |
1.298420E-01 |
| N1-vs-N2 |
1.117180E-01 |
|
|
